Table 4.
Variables | PTGDS high | PTGDS low | P-value |
---|---|---|---|
Number of cases | 41 (40.8%) | 57 (59.2%) | |
Age at diagnosis (years) | 51.4 ± 7.8 | 52.5 ± 9.4 | 0.65 |
BMI (kg/m2) | 23.12 ± 3.10 | 25.59 ± 4.25 | 0.01** |
Breast-conserving surgery | 18 (43.9%) | 32 (56.1%) | 0.32 |
ALD | 10 (24.4%) | 20 (35.1%) | 0.36 |
Molecular subtype | 0.04* | ||
Luminal A | 3 (7.3%) | 4 (7.0%) | |
Luminal B | 10 (24.4%) | 26 (45.6%) | |
Her2 | 8 (19.5%) | 14 (24.6%) | |
TNBC | 20 (48.8%) | 13 (22.8%) | |
Ki-67 | 0.37 | 0.39 | 0.88 |
T stage | 0.04* | ||
I | 32 (78.0%) | 32 (56.1%) | |
II-III | 9 (22.0%) | 25 (43.9%) | |
N stage | 0.54 | ||
N0 | 33 (80.5%) | 41 (71.9%) | |
N1-N3 | 8 (19.5%) | 16 (28.1%) | |
Pathological stages | 0.11 | ||
I | 24 (58.5%) | 24 (42.1%) | |
II | 16 (39.0%) | 26 (45.6%) | |
III | 1 (2.4%) | 7 (12.3%) | |
Histological grade | 0.55 | ||
G1 | 2 (4.9%) | 1 (1.8%) | |
G2 | 20 (48.8%) | 33 (57.9%) | |
G3 | 19 (46.3%) | 23 (40.3%) | |
Percentage of invasive tumor | 0.86 ± 0.23 | 0.81 ± 0.17 | 0.44 |
TILs | 0.34 ± 0.23 | 0.24 ± 0.18 | 0.12 |
PTGDS intensity | 2.75 ± 0.44 | 1.34 ± 1.11 | <0.0001*** |
CI, confidence interval; *P < 0.05, **P < 0.01, ***P < 0.001.